MedPath

Role of dexmedetomidine and magnesium sulphate in controlling the stress response of intubation in patients undergoing operation.

Not Applicable
Conditions
Health Condition 1: 4- Measurement and Monitoring
Registration Number
CTRI/2021/06/034217
Lead Sponsor
Yangchen Bhutia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of either sex

Patients with ASA physical grade I or II

Patients with age group 18 to 60 years undergoing elective surgery under general anesthesia

Patients willing to give written consent

Exclusion Criteria

Patients refusal

Anticipated difficult airway (mallampati score >III, thyromental distance <6.5cm)

Patients with diabetes and hypertension

Pregnant or breast feeding mother

Patients with respiratory, cardiac,neurological,renal or liver diseases

Patients with gastro-oesophageal reflux

Patients with known allergy to drugs used for induction of anaesthesia

Psychiatric patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare efficacy of dexmedetomidine and magnesium sulphate on the attenuation of stress response of laryngoscopy and intubation in patients undergoing general anaesthesia.Timepoint: Baseline <br/ ><br>Before intubation, just after intubation ,and also at 1,3,5,10 minutes after intubation.
Secondary Outcome Measures
NameTimeMethod
To compare between dexmedetomidine and magnesium sulphate, a better drug for controlling the stress response.Timepoint: Baseline <br/ ><br>Before intubation, just after intubation, and also at 1,3,5,10 minutes after intubation
© Copyright 2025. All Rights Reserved by MedPath